Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Med Case Rep ; 11(1): 166, 2017 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-28637499

RESUMO

BACKGROUND: Granulosa cell tumor of the ovary is the most frequent sex cord stromal tumor and represents 2 to 5% of all primary ovarian cancers. Ovarian granulosa cell tumor is a malignant tumor with slow progression and in some cases this tumor is hormonally active. The recurrence of granulosa cell tumor often happens after 5 years. CASE PRESENTATION: We describe two cases of postmenopausal women with adult-type granulosa cell tumors of the ovary. Patient 1 is a 49-year-old European woman with a recurrent tumor; patient 2 is a 55-year-old European woman without recurrence of tumor. Urinary steroid profiles of patient 1 were monitored during a 5-year period starting from before an operation (13 samples). In patient 2, the urinary steroid profiles were monitored during a 3-year period starting from after an operation (six samples). The 24-hour urinary samples were examined and the urinary concentration of 20 androgen, progesterone, and corticoid metabolites was quantitatively determined by gas chromatography-mass spectrometry with selected ion-monitoring mode. CONCLUSIONS: Based on these cases a correlation could be observed between increased levels of the urinary steroids and the recurrence of ovarian granulosa cell tumor; therefore, we concluded that a urinary steroid profile could be a more effective method to follow-up such patients compared to the traditional serum hormones determinations supplemented with conventional tumor markers.


Assuntos
Biomarcadores Tumorais/urina , Tumor de Células da Granulosa/urina , Recidiva Local de Neoplasia/urina , Neoplasias Ovarianas/urina , Esteroides/urina , Androgênios/urina , Feminino , Tumor de Células da Granulosa/microbiologia , Tumor de Células da Granulosa/patologia , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Neoplasias Ovarianas/metabolismo , Neoplasias Ovarianas/patologia , Ovário/diagnóstico por imagem , Ovário/patologia , Progesterona/urina , Esteroides/metabolismo , Tomografia Computadorizada por Raios X
2.
Gynecol Endocrinol ; 26(1): 10-5, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19670000

RESUMO

OBJECTIVE: The potential role of androgen metabolism as co-factors in the development of carcinoma endometrii was investigated. DESIGN: The urinary concentration of 23 androgen, progesterone and corticoid metabolites was quantitatively determined by gas chromatography-mass spectrometry with selected ion-monitoring. We obtained 24-h urine samples from 13 patients with adenocarcinoma endometrii and from 10 age-matched normal female subjects. In the course of the urinary steroid determination, we observed changes in the steroid profiles in the disease examined compared to the same age and same sex control group. Profiling urinary steroids has to give comprehensive information about the synthesis of steroids including the glandular and peripheral steroid metabolisms. RESULTS: The concentrations of 16-hydroxy- dehydroepiandrosterone, pregnanediol and pregnenediol were not significantly different in the two groups. The concentrations of androsterone, etiocholanolone, 11beta-hydroxy-androsterone, 11beta-hydroxy-etiocholanolone, pregnanetriol, pregnenetriol, tetrahydrocortisone, tetrahydro-11-dehydrocorticosterone, tetrahydro-corticosterone, allo-tetrahydro-corticosterone, tetrahydrocortisol, allo-tetrahydrocortisol, alpha-cortolone, beta-cortolone and alpha-cortol were significantly lower in the postmenopausal women with adenocarcinoma than in the controls. CONCLUSION: The changes in the concentrations of single metabolites point out the important role of steroid group, thus providing help in the recognition and treatment of diseased states.


Assuntos
Carcinoma Endometrioide/urina , Neoplasias do Endométrio/urina , Pós-Menopausa/urina , Esteroides/urina , Idoso , Carcinoma Endometrioide/sangue , Carcinoma Endometrioide/metabolismo , Estudos de Casos e Controles , Sulfato de Desidroepiandrosterona/sangue , Sulfato de Desidroepiandrosterona/urina , Neoplasias do Endométrio/sangue , Neoplasias do Endométrio/metabolismo , Estradiol/sangue , Estradiol/metabolismo , Estradiol/urina , Feminino , Humanos , Metaboloma , Pessoa de Meia-Idade , Pós-Menopausa/sangue , Progesterona/sangue , Progesterona/metabolismo , Progesterona/urina , Esteroides/metabolismo , Urinálise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA